Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice

Elena Quaglino, Manuela Iezzi, Cristina Mastini, Augusto Amici, Federica Pericle, Emma Di Carlo, Serenella M. Pupa, Carla De Giovanni, Michela Spadaro, Claudia Curcio, Pier Luigi Lollini, Piero Musiani, Guido Forni, Federica Cavallo

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

The transforming rat Her-2/neu oncogene embedded into the genome of virgin transgenic BALB/c mice (BALB-neuT) provokes the development of an invasive carcinoma in each of their 10 mammary glands. i.m. vaccination with DNA plasmids coding for the extracellular and transmembrane domains of the protein product of the Her-2/neu oncogene started when mice already display multifocal in situ carcinomas temporarily halts neoplastic progression, but all mice develop a tumor by week 43. By contrast, progressive clearance of neoplastic lesions and complete protection of all 1-year-old mice are achieved when the same plasmids are electroporated at 10-week intervals. Pathological findings, in vitro tests, and the results from the immunization of both IFN-γ and immunoglobulin gene knockout BALB-neuT mice, and of adoptive transfer experiments, all suggest that tumor clearance rests on the combination of antibodies and IFN-γ-releasing T cells. These findings show that an appropriate vaccine effectively inhibits the progression of multifocal preneoplastic lesions.

Original languageEnglish
Pages (from-to)2858-2864
Number of pages7
JournalCancer Research
Volume64
Issue number8
DOIs
Publication statusPublished - Apr 15 2004

Fingerprint

DNA Vaccines
Transgenic Mice
Breast Neoplasms
Oncogenes
Plasmids
Immunoglobulin Genes
Gene Knockout Techniques
Adoptive Transfer
Carcinoma in Situ
Human Mammary Glands
Immunization
Neoplasms
Vaccination
Vaccines
Genome
Carcinoma
T-Lymphocytes
Antibodies
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Quaglino, E., Iezzi, M., Mastini, C., Amici, A., Pericle, F., Di Carlo, E., ... Cavallo, F. (2004). Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice. Cancer Research, 64(8), 2858-2864. https://doi.org/10.1158/0008-5472.CAN-03-2962

Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice. / Quaglino, Elena; Iezzi, Manuela; Mastini, Cristina; Amici, Augusto; Pericle, Federica; Di Carlo, Emma; Pupa, Serenella M.; De Giovanni, Carla; Spadaro, Michela; Curcio, Claudia; Lollini, Pier Luigi; Musiani, Piero; Forni, Guido; Cavallo, Federica.

In: Cancer Research, Vol. 64, No. 8, 15.04.2004, p. 2858-2864.

Research output: Contribution to journalArticle

Quaglino, E, Iezzi, M, Mastini, C, Amici, A, Pericle, F, Di Carlo, E, Pupa, SM, De Giovanni, C, Spadaro, M, Curcio, C, Lollini, PL, Musiani, P, Forni, G & Cavallo, F 2004, 'Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice', Cancer Research, vol. 64, no. 8, pp. 2858-2864. https://doi.org/10.1158/0008-5472.CAN-03-2962
Quaglino, Elena ; Iezzi, Manuela ; Mastini, Cristina ; Amici, Augusto ; Pericle, Federica ; Di Carlo, Emma ; Pupa, Serenella M. ; De Giovanni, Carla ; Spadaro, Michela ; Curcio, Claudia ; Lollini, Pier Luigi ; Musiani, Piero ; Forni, Guido ; Cavallo, Federica. / Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice. In: Cancer Research. 2004 ; Vol. 64, No. 8. pp. 2858-2864.
@article{9e2722efcb724ba88dcf526ed88d93cf,
title = "Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice",
abstract = "The transforming rat Her-2/neu oncogene embedded into the genome of virgin transgenic BALB/c mice (BALB-neuT) provokes the development of an invasive carcinoma in each of their 10 mammary glands. i.m. vaccination with DNA plasmids coding for the extracellular and transmembrane domains of the protein product of the Her-2/neu oncogene started when mice already display multifocal in situ carcinomas temporarily halts neoplastic progression, but all mice develop a tumor by week 43. By contrast, progressive clearance of neoplastic lesions and complete protection of all 1-year-old mice are achieved when the same plasmids are electroporated at 10-week intervals. Pathological findings, in vitro tests, and the results from the immunization of both IFN-γ and immunoglobulin gene knockout BALB-neuT mice, and of adoptive transfer experiments, all suggest that tumor clearance rests on the combination of antibodies and IFN-γ-releasing T cells. These findings show that an appropriate vaccine effectively inhibits the progression of multifocal preneoplastic lesions.",
author = "Elena Quaglino and Manuela Iezzi and Cristina Mastini and Augusto Amici and Federica Pericle and {Di Carlo}, Emma and Pupa, {Serenella M.} and {De Giovanni}, Carla and Michela Spadaro and Claudia Curcio and Lollini, {Pier Luigi} and Piero Musiani and Guido Forni and Federica Cavallo",
year = "2004",
month = "4",
day = "15",
doi = "10.1158/0008-5472.CAN-03-2962",
language = "English",
volume = "64",
pages = "2858--2864",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice

AU - Quaglino, Elena

AU - Iezzi, Manuela

AU - Mastini, Cristina

AU - Amici, Augusto

AU - Pericle, Federica

AU - Di Carlo, Emma

AU - Pupa, Serenella M.

AU - De Giovanni, Carla

AU - Spadaro, Michela

AU - Curcio, Claudia

AU - Lollini, Pier Luigi

AU - Musiani, Piero

AU - Forni, Guido

AU - Cavallo, Federica

PY - 2004/4/15

Y1 - 2004/4/15

N2 - The transforming rat Her-2/neu oncogene embedded into the genome of virgin transgenic BALB/c mice (BALB-neuT) provokes the development of an invasive carcinoma in each of their 10 mammary glands. i.m. vaccination with DNA plasmids coding for the extracellular and transmembrane domains of the protein product of the Her-2/neu oncogene started when mice already display multifocal in situ carcinomas temporarily halts neoplastic progression, but all mice develop a tumor by week 43. By contrast, progressive clearance of neoplastic lesions and complete protection of all 1-year-old mice are achieved when the same plasmids are electroporated at 10-week intervals. Pathological findings, in vitro tests, and the results from the immunization of both IFN-γ and immunoglobulin gene knockout BALB-neuT mice, and of adoptive transfer experiments, all suggest that tumor clearance rests on the combination of antibodies and IFN-γ-releasing T cells. These findings show that an appropriate vaccine effectively inhibits the progression of multifocal preneoplastic lesions.

AB - The transforming rat Her-2/neu oncogene embedded into the genome of virgin transgenic BALB/c mice (BALB-neuT) provokes the development of an invasive carcinoma in each of their 10 mammary glands. i.m. vaccination with DNA plasmids coding for the extracellular and transmembrane domains of the protein product of the Her-2/neu oncogene started when mice already display multifocal in situ carcinomas temporarily halts neoplastic progression, but all mice develop a tumor by week 43. By contrast, progressive clearance of neoplastic lesions and complete protection of all 1-year-old mice are achieved when the same plasmids are electroporated at 10-week intervals. Pathological findings, in vitro tests, and the results from the immunization of both IFN-γ and immunoglobulin gene knockout BALB-neuT mice, and of adoptive transfer experiments, all suggest that tumor clearance rests on the combination of antibodies and IFN-γ-releasing T cells. These findings show that an appropriate vaccine effectively inhibits the progression of multifocal preneoplastic lesions.

UR - http://www.scopus.com/inward/record.url?scp=4043147286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043147286&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-03-2962

DO - 10.1158/0008-5472.CAN-03-2962

M3 - Article

C2 - 15087404

AN - SCOPUS:4043147286

VL - 64

SP - 2858

EP - 2864

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 8

ER -